NSE filing, NSE: APSISAERO. Summary written from the filing by ALFA Finder's alert engine.
Apsis Aerocom Ltd: key numbers
- Share price
- ₹526.25
- Market cap
- ₹634.2 Cr
- Revenue (annual)
- ₹30.65 Cr
- Net profit (annual)
- ₹7.51 Cr
- P/E (TTM)
- 84.4×Sector 52.0×
- Promoter holding
- 73.02%
- FII holding
- 0.39%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Apsis Aerocom Ltd
All →Apsis Aerocom Annual General Meeting
Apsis Aerocom Limited conducted its 4th Annual General Meeting on September 26, 2026, where shareholders considered financial statements and the re-appointment of a director.
Apsis Aerocom Bags ₹4.3 Cr Order from A local customer in Healthcare segment
Apsis Aerocom received a supply order worth ₹4.30 Crore from a domestic healthcare customer. Delivery is due within 7 months under the contract.
- Value
- ₹4.30 Cr
- From
- A local customer in Healthcare segment (name undisclosed due to confidentiality)
- Execution
- Within 7 months
Apsis Aerocom Other Announcement
Apsis Aerocom Limited has notified shareholders about the dispatch of letters regarding the 4th AGM and Annual Report, complying with SEBI Regulation 36(1)(b).
Apsis Aerocom Annual General Meeting
Apsis Aerocom Limited has issued a notice for its Annual General Meeting scheduled for September 26, 2026. Shareholders will consider financial statements and director re-appointment.
Apsis Aerocom Board Meeting Outcome
Apsis Aerocom Limited approved its Board Report for FY2026 and the notice for the upcoming Annual General Meeting scheduled on September 26, 2026.
Apsis Aerocom Capacity Expansion
Apsis Aerocom Limited has inaugurated its Unit II, a new manufacturing unit and branch office in Bengaluru. The facility is located at Hitech Defence and Aerospace Park.
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.